Abstract
The revival of BNCT over the last decade, stimulated the formation in 1987 of the European Collaboration group on BNCT. The multi-disciplinary nature of BNCT has drawn together groups of researchers from many European institutes who are now collaborating in an effort to achieve the implementation of BNCT in Europe at the earliest possible date. To accomplish this, it was well recognised that of the two basic preconditions for successful BNCT, namely: i) the accumulation of enough boron in the tumour cells with sufficient clearance of the surrounding tissues and ii) the delivery of enough thermal neutrons at the tumour site to give rise to a sufficient number of capture events; it was the latter, with respect to identifying a suitable neutron source in Europe, that needed the most attention from the Collaboration group. The former condition had to some extent been resolved with the use of BSH, for example, and the development of other potentially promising compounds. For the latter condition, the neutron source had to have not only the special prerequisite nuclear and geometric characteristics, but also the financial resources and expertise to realise a facility. It was for this reason (but not the only), that the High Flux Materials Testing Reactor (HFR) at Petten became involved in the European BNCT project.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Gabel, D., “Approach to Boron Neutron Capture Therapy in Europe: Goals of a European Collaboration on Boron Neutron Capture Therapy”, Proc. 2nd. Eur. Particle Accelerator Conf., Nice, (1990)
Röttger, H. et al.,“High Flux Materials Testing Reactor Petten, Characteristics of the Facilities and Standard Irradiation Devices”, Report“, EUR 5700 EN, (1986/87).
Moss, R.L., “Progress towards Boron Neutron Capture Therapy at the High Flux Reactor Petten”, Neutron Beam Design, Development and Performance for Neutron Capture Therapy, Basic Life Sciences, Vol.54, Plenum Press, (1990).
Constantine, G., Watkins, P.R.D., Perks, C., Dellafield, H., Ross, D., Voorbraak, W., Paardekooper, A., Freudenreich, W., Stecher-Rasmussen, F., Moss, R.L., “Progress in neutron beam development at the HFR Petten (Feasibility study for a BNCT facility)”, Proc. 7th ASTM-EURATOM Symposium on Reactor Dosimetry, August 1990, Strasbourg, France.
Breimeister, J.F.(Ed), “MCNP - A General Monte Carlo Code for Neutron and Photon Transport”, LA-7596-M, Rev.2.
Gavin, P.R., Kraft, S.L., Wendling, L.R. and Miller, D.L., “Canine spontaneous brain tumors - a large animal model for BNCT”, Strahlenther. Onkol. 165 (1989).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Moss, R.L., Stecher-Rasmussen, F., Huiskamp, R., Dewit, L., Mijnheer, B. (1992). The Petten BNCT Project. In: Allen, B.J., Moore, D.E., Harrington, B.V. (eds) Progress in Neutron Capture Therapy for Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3384-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3384-9_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6494-8
Online ISBN: 978-1-4615-3384-9
eBook Packages: Springer Book Archive